Jarlego, Cliff S.

HRN: 23 23 12  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/29/2023
07/05/2023
IV
1.5gm
Q6
Acute Tonsillopharyngitis
Waiting Final Action 
06/30/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
06/30/2023
07/06/2023
ORAL
5ml
Bid
Oral Thrush
Waiting Final Action 
06/30/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
06/30/2023
06/30/2023
IV
150mg
Q24
Oral Thrush
Waiting Final Action 
06/30/2023
AZITHROMYCIN 500MG TABLET (TAB)
06/30/2023
07/05/2023
PO
500mg
OD
ATP
Waiting Final Action 
07/01/2023
CEFTRIAXONE 1G (VIAL)
07/01/2023
07/08/2023
IVT
2g
Q24H
CAP MR
Waiting Final Action 
07/05/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/05/2023
07/11/2023
ORAL- SWISH AND SWALLOW
5 Ml
Q6
Oral Thrush
Waiting Final Action 
07/06/2023
MUPIROCIN 2%, 15G (TUBE)
07/06/2023
07/13/2023
TOPICAL
2%
TID
Bed Sore
Waiting Final Action 
07/08/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/08/2023
07/16/2023
IV
4.5gm
QID
Pneumonia High Risk
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: